nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—AOX1—Methotrexate—colon cancer	0.657	1	CbGbCtD
Brimonidine—Common cold—Fluorouracil—colon cancer	0.011	0.032	CcSEcCtD
Brimonidine—Rosacea—Capecitabine—colon cancer	0.00917	0.0267	CcSEcCtD
Brimonidine—Scab—Fluorouracil—colon cancer	0.00901	0.0263	CcSEcCtD
Brimonidine—Allergic contact dermatitis—Fluorouracil—colon cancer	0.0082	0.0239	CcSEcCtD
Brimonidine—Punctate keratitis—Capecitabine—colon cancer	0.00792	0.0231	CcSEcCtD
Brimonidine—Miosis—Irinotecan—colon cancer	0.00716	0.0209	CcSEcCtD
Brimonidine—Skin irritation—Fluorouracil—colon cancer	0.00662	0.0193	CcSEcCtD
Brimonidine—Scab—Capecitabine—colon cancer	0.00629	0.0184	CcSEcCtD
Brimonidine—Blindness—Vincristine—colon cancer	0.00555	0.0162	CcSEcCtD
Brimonidine—Lacrimation—Irinotecan—colon cancer	0.00508	0.0148	CcSEcCtD
Brimonidine—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.00487	0.0142	CcSEcCtD
Brimonidine—Lacrimation—Fluorouracil—colon cancer	0.00487	0.0142	CcSEcCtD
Brimonidine—Blepharitis—Fluorouracil—colon cancer	0.00466	0.0136	CcSEcCtD
Brimonidine—Peripheral coldness—Capecitabine—colon cancer	0.0042	0.0123	CcSEcCtD
Brimonidine—Stinging—Fluorouracil—colon cancer	0.00353	0.0103	CcSEcCtD
Brimonidine—Vasodilation procedure—Irinotecan—colon cancer	0.0034	0.00993	CcSEcCtD
Brimonidine—Vasodilation—Irinotecan—colon cancer	0.0034	0.00993	CcSEcCtD
Brimonidine—Eye irritation—Fluorouracil—colon cancer	0.00335	0.00979	CcSEcCtD
Brimonidine—Lacrimation increased—Irinotecan—colon cancer	0.00324	0.00947	CcSEcCtD
Brimonidine—Respiratory failure—Vincristine—colon cancer	0.00313	0.00912	CcSEcCtD
Brimonidine—Lacrimation increased—Fluorouracil—colon cancer	0.00311	0.00907	CcSEcCtD
Brimonidine—Keratitis—Capecitabine—colon cancer	0.00309	0.009	CcSEcCtD
Brimonidine—Dermatitis contact—Fluorouracil—colon cancer	0.00283	0.00826	CcSEcCtD
Brimonidine—Coma—Vincristine—colon cancer	0.00281	0.00819	CcSEcCtD
Brimonidine—Photophobia—Fluorouracil—colon cancer	0.00269	0.00785	CcSEcCtD
Brimonidine—Osteoporosis—Methotrexate—colon cancer	0.00266	0.00775	CcSEcCtD
Brimonidine—Coma—Fluorouracil—colon cancer	0.00262	0.00764	CcSEcCtD
Brimonidine—Swelling—Fluorouracil—colon cancer	0.00236	0.00688	CcSEcCtD
Brimonidine—Hypoxia—Methotrexate—colon cancer	0.00235	0.00684	CcSEcCtD
Brimonidine—Eye irritation—Capecitabine—colon cancer	0.00234	0.00684	CcSEcCtD
Brimonidine—Visual disturbance—Irinotecan—colon cancer	0.00229	0.00668	CcSEcCtD
Brimonidine—Lacrimation increased—Capecitabine—colon cancer	0.00217	0.00634	CcSEcCtD
Brimonidine—Osteoarthritis—Irinotecan—colon cancer	0.00217	0.00633	CcSEcCtD
Brimonidine—Burning sensation—Methotrexate—colon cancer	0.00214	0.00626	CcSEcCtD
Brimonidine—Lethargy—Fluorouracil—colon cancer	0.00212	0.00619	CcSEcCtD
Brimonidine—Cyanosis—Methotrexate—colon cancer	0.0021	0.00614	CcSEcCtD
Brimonidine—Cataract—Capecitabine—colon cancer	0.0021	0.00613	CcSEcCtD
Brimonidine—Osteoarthritis—Fluorouracil—colon cancer	0.00208	0.00607	CcSEcCtD
Brimonidine—Dry skin—Fluorouracil—colon cancer	0.00191	0.00556	CcSEcCtD
Brimonidine—Nasopharyngitis—Fluorouracil—colon cancer	0.00186	0.00542	CcSEcCtD
Brimonidine—Dry eye—Capecitabine—colon cancer	0.00185	0.00539	CcSEcCtD
Brimonidine—Apnoea—Methotrexate—colon cancer	0.00176	0.00513	CcSEcCtD
Brimonidine—Abnormal vision—Capecitabine—colon cancer	0.00175	0.00509	CcSEcCtD
Brimonidine—Depression—Vincristine—colon cancer	0.00171	0.005	CcSEcCtD
Brimonidine—Diabetes mellitus—Capecitabine—colon cancer	0.00167	0.00487	CcSEcCtD
Brimonidine—Swelling—Capecitabine—colon cancer	0.00165	0.0048	CcSEcCtD
Brimonidine—Eye pain—Capecitabine—colon cancer	0.00161	0.0047	CcSEcCtD
Brimonidine—Conjunctivitis—Fluorouracil—colon cancer	0.00156	0.00454	CcSEcCtD
Brimonidine—Bradycardia—Irinotecan—colon cancer	0.00153	0.00446	CcSEcCtD
Brimonidine—Respiratory failure—Methotrexate—colon cancer	0.00152	0.00443	CcSEcCtD
Brimonidine—Rhinitis—Irinotecan—colon cancer	0.00151	0.00439	CcSEcCtD
Brimonidine—Sinusitis—Fluorouracil—colon cancer	0.0015	0.00439	CcSEcCtD
Brimonidine—Arthritis—Capecitabine—colon cancer	0.00149	0.00436	CcSEcCtD
Brimonidine—Lethargy—Capecitabine—colon cancer	0.00148	0.00433	CcSEcCtD
Brimonidine—Osteoarthritis—Capecitabine—colon cancer	0.00145	0.00424	CcSEcCtD
Brimonidine—Visual impairment—Irinotecan—colon cancer	0.00145	0.00422	CcSEcCtD
Brimonidine—Rhinitis—Fluorouracil—colon cancer	0.00144	0.00421	CcSEcCtD
Brimonidine—Cardiac disorder—Vincristine—colon cancer	0.00143	0.00418	CcSEcCtD
Brimonidine—Pharyngitis—Fluorouracil—colon cancer	0.00143	0.00416	CcSEcCtD
Brimonidine—Face oedema—Capecitabine—colon cancer	0.0014	0.00409	CcSEcCtD
Brimonidine—Angiopathy—Vincristine—colon cancer	0.0014	0.00408	CcSEcCtD
Brimonidine—Cardiac disorder—Irinotecan—colon cancer	0.00139	0.00407	CcSEcCtD
Brimonidine—Flushing—Irinotecan—colon cancer	0.00139	0.00407	CcSEcCtD
Brimonidine—Mediastinal disorder—Vincristine—colon cancer	0.00139	0.00405	CcSEcCtD
Brimonidine—Angiopathy—Irinotecan—colon cancer	0.00136	0.00398	CcSEcCtD
Brimonidine—Coma—Methotrexate—colon cancer	0.00136	0.00397	CcSEcCtD
Brimonidine—Immune system disorder—Irinotecan—colon cancer	0.00136	0.00396	CcSEcCtD
Brimonidine—Mediastinal disorder—Irinotecan—colon cancer	0.00135	0.00395	CcSEcCtD
Brimonidine—Mental disorder—Vincristine—colon cancer	0.00135	0.00394	CcSEcCtD
Brimonidine—Arrhythmia—Irinotecan—colon cancer	0.00134	0.00391	CcSEcCtD
Brimonidine—Dry skin—Capecitabine—colon cancer	0.00133	0.00389	CcSEcCtD
Brimonidine—Nasopharyngitis—Capecitabine—colon cancer	0.0013	0.00379	CcSEcCtD
Brimonidine—Arrhythmia—Fluorouracil—colon cancer	0.00128	0.00375	CcSEcCtD
Brimonidine—Influenza—Capecitabine—colon cancer	0.00126	0.00366	CcSEcCtD
Brimonidine—Erythema—Fluorouracil—colon cancer	0.00125	0.00365	CcSEcCtD
Brimonidine—Diabetes mellitus—Methotrexate—colon cancer	0.00124	0.00363	CcSEcCtD
Brimonidine—Bronchitis—Capecitabine—colon cancer	0.00121	0.00352	CcSEcCtD
Brimonidine—Vision blurred—Fluorouracil—colon cancer	0.00118	0.00344	CcSEcCtD
Brimonidine—Syncope—Irinotecan—colon cancer	0.00117	0.00342	CcSEcCtD
Brimonidine—Hypertension—Vincristine—colon cancer	0.00116	0.00338	CcSEcCtD
Brimonidine—Loss of consciousness—Irinotecan—colon cancer	0.00115	0.00335	CcSEcCtD
Brimonidine—Myalgia—Vincristine—colon cancer	0.00114	0.00333	CcSEcCtD
Brimonidine—Visual disturbance—Methotrexate—colon cancer	0.00114	0.00333	CcSEcCtD
Brimonidine—Cough—Irinotecan—colon cancer	0.00114	0.00333	CcSEcCtD
Brimonidine—Hypertension—Irinotecan—colon cancer	0.00113	0.00329	CcSEcCtD
Brimonidine—Depression—Capecitabine—colon cancer	0.00112	0.00326	CcSEcCtD
Brimonidine—Lethargy—Methotrexate—colon cancer	0.0011	0.00322	CcSEcCtD
Brimonidine—Discomfort—Irinotecan—colon cancer	0.0011	0.00321	CcSEcCtD
Brimonidine—Oedema—Vincristine—colon cancer	0.0011	0.0032	CcSEcCtD
Brimonidine—Infection—Vincristine—colon cancer	0.00109	0.00318	CcSEcCtD
Brimonidine—Conjunctivitis—Capecitabine—colon cancer	0.00109	0.00318	CcSEcCtD
Brimonidine—Osteoarthritis—Methotrexate—colon cancer	0.00108	0.00316	CcSEcCtD
Brimonidine—Nervous system disorder—Vincristine—colon cancer	0.00107	0.00313	CcSEcCtD
Brimonidine—Oedema—Irinotecan—colon cancer	0.00107	0.00311	CcSEcCtD
Brimonidine—Chest pain—Fluorouracil—colon cancer	0.00107	0.00311	CcSEcCtD
Brimonidine—Myalgia—Fluorouracil—colon cancer	0.00107	0.00311	CcSEcCtD
Brimonidine—Infection—Irinotecan—colon cancer	0.00106	0.00309	CcSEcCtD
Brimonidine—Discomfort—Fluorouracil—colon cancer	0.00105	0.00307	CcSEcCtD
Brimonidine—Shock—Irinotecan—colon cancer	0.00105	0.00306	CcSEcCtD
Brimonidine—Nervous system disorder—Irinotecan—colon cancer	0.00105	0.00305	CcSEcCtD
Brimonidine—Hypotension—Vincristine—colon cancer	0.00102	0.00299	CcSEcCtD
Brimonidine—Bradycardia—Capecitabine—colon cancer	0.00102	0.00299	CcSEcCtD
Brimonidine—Oedema—Fluorouracil—colon cancer	0.00102	0.00298	CcSEcCtD
Brimonidine—Infection—Fluorouracil—colon cancer	0.00102	0.00296	CcSEcCtD
Brimonidine—Rhinitis—Capecitabine—colon cancer	0.00101	0.00294	CcSEcCtD
Brimonidine—Nervous system disorder—Fluorouracil—colon cancer	0.001	0.00292	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000998	0.00291	CcSEcCtD
Brimonidine—Pharyngitis—Capecitabine—colon cancer	0.000997	0.00291	CcSEcCtD
Brimonidine—Tachycardia—Fluorouracil—colon cancer	0.000997	0.00291	CcSEcCtD
Brimonidine—Hypotension—Irinotecan—colon cancer	0.000997	0.00291	CcSEcCtD
Brimonidine—Insomnia—Vincristine—colon cancer	0.000991	0.00289	CcSEcCtD
Brimonidine—Paraesthesia—Vincristine—colon cancer	0.000984	0.00287	CcSEcCtD
Brimonidine—Visual impairment—Capecitabine—colon cancer	0.000968	0.00283	CcSEcCtD
Brimonidine—Insomnia—Irinotecan—colon cancer	0.000965	0.00282	CcSEcCtD
Brimonidine—Paraesthesia—Irinotecan—colon cancer	0.000958	0.0028	CcSEcCtD
Brimonidine—Hypotension—Fluorouracil—colon cancer	0.000955	0.00279	CcSEcCtD
Brimonidine—Dyspnoea—Irinotecan—colon cancer	0.000951	0.00278	CcSEcCtD
Brimonidine—Somnolence—Irinotecan—colon cancer	0.000948	0.00277	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Vincristine—colon cancer	0.000946	0.00276	CcSEcCtD
Brimonidine—Fatigue—Vincristine—colon cancer	0.000944	0.00276	CcSEcCtD
Brimonidine—Eye disorder—Capecitabine—colon cancer	0.000939	0.00274	CcSEcCtD
Brimonidine—Dyspepsia—Irinotecan—colon cancer	0.000939	0.00274	CcSEcCtD
Brimonidine—Pain—Vincristine—colon cancer	0.000937	0.00273	CcSEcCtD
Brimonidine—Flushing—Capecitabine—colon cancer	0.000933	0.00272	CcSEcCtD
Brimonidine—Cardiac disorder—Capecitabine—colon cancer	0.000933	0.00272	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000931	0.00272	CcSEcCtD
Brimonidine—Insomnia—Fluorouracil—colon cancer	0.000924	0.0027	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000921	0.00269	CcSEcCtD
Brimonidine—Fatigue—Irinotecan—colon cancer	0.00092	0.00268	CcSEcCtD
Brimonidine—Paraesthesia—Fluorouracil—colon cancer	0.000917	0.00268	CcSEcCtD
Brimonidine—Pain—Irinotecan—colon cancer	0.000912	0.00266	CcSEcCtD
Brimonidine—Angiopathy—Capecitabine—colon cancer	0.000912	0.00266	CcSEcCtD
Brimonidine—Dyspnoea—Fluorouracil—colon cancer	0.000911	0.00266	CcSEcCtD
Brimonidine—Somnolence—Fluorouracil—colon cancer	0.000908	0.00265	CcSEcCtD
Brimonidine—Immune system disorder—Capecitabine—colon cancer	0.000908	0.00265	CcSEcCtD
Brimonidine—Mediastinal disorder—Capecitabine—colon cancer	0.000906	0.00264	CcSEcCtD
Brimonidine—Dyspepsia—Fluorouracil—colon cancer	0.000899	0.00262	CcSEcCtD
Brimonidine—Arrhythmia—Capecitabine—colon cancer	0.000898	0.00262	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000882	0.00257	CcSEcCtD
Brimonidine—Mental disorder—Capecitabine—colon cancer	0.00088	0.00257	CcSEcCtD
Brimonidine—Erythema—Capecitabine—colon cancer	0.000875	0.00255	CcSEcCtD
Brimonidine—Pain—Fluorouracil—colon cancer	0.000874	0.00255	CcSEcCtD
Brimonidine—Dysgeusia—Capecitabine—colon cancer	0.000857	0.0025	CcSEcCtD
Brimonidine—Drowsiness—Methotrexate—colon cancer	0.000833	0.00243	CcSEcCtD
Brimonidine—Depression—Methotrexate—colon cancer	0.000831	0.00242	CcSEcCtD
Brimonidine—Vision blurred—Capecitabine—colon cancer	0.000824	0.00241	CcSEcCtD
Brimonidine—Conjunctivitis—Methotrexate—colon cancer	0.00081	0.00236	CcSEcCtD
Brimonidine—Hypersensitivity—Vincristine—colon cancer	0.000807	0.00235	CcSEcCtD
Brimonidine—Hypersensitivity—Irinotecan—colon cancer	0.000786	0.00229	CcSEcCtD
Brimonidine—Asthenia—Vincristine—colon cancer	0.000786	0.00229	CcSEcCtD
Brimonidine—Syncope—Capecitabine—colon cancer	0.000784	0.00229	CcSEcCtD
Brimonidine—Palpitations—Capecitabine—colon cancer	0.000773	0.00226	CcSEcCtD
Brimonidine—Loss of consciousness—Capecitabine—colon cancer	0.000769	0.00224	CcSEcCtD
Brimonidine—Asthenia—Irinotecan—colon cancer	0.000765	0.00223	CcSEcCtD
Brimonidine—Cough—Capecitabine—colon cancer	0.000763	0.00223	CcSEcCtD
Brimonidine—Hypertension—Capecitabine—colon cancer	0.000755	0.0022	CcSEcCtD
Brimonidine—Hypersensitivity—Fluorouracil—colon cancer	0.000753	0.0022	CcSEcCtD
Brimonidine—Chest pain—Capecitabine—colon cancer	0.000745	0.00217	CcSEcCtD
Brimonidine—Myalgia—Capecitabine—colon cancer	0.000745	0.00217	CcSEcCtD
Brimonidine—Arthralgia—Capecitabine—colon cancer	0.000745	0.00217	CcSEcCtD
Brimonidine—Pharyngitis—Methotrexate—colon cancer	0.000742	0.00217	CcSEcCtD
Brimonidine—Anxiety—Capecitabine—colon cancer	0.000742	0.00217	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00074	0.00216	CcSEcCtD
Brimonidine—Discomfort—Capecitabine—colon cancer	0.000736	0.00215	CcSEcCtD
Brimonidine—Dry mouth—Capecitabine—colon cancer	0.000728	0.00213	CcSEcCtD
Brimonidine—Dizziness—Vincristine—colon cancer	0.000724	0.00211	CcSEcCtD
Brimonidine—Pruritus—Fluorouracil—colon cancer	0.000723	0.00211	CcSEcCtD
Brimonidine—Visual impairment—Methotrexate—colon cancer	0.000721	0.0021	CcSEcCtD
Brimonidine—Oedema—Capecitabine—colon cancer	0.000714	0.00208	CcSEcCtD
Brimonidine—Infection—Capecitabine—colon cancer	0.000709	0.00207	CcSEcCtD
Brimonidine—Dizziness—Irinotecan—colon cancer	0.000705	0.00206	CcSEcCtD
Brimonidine—Shock—Capecitabine—colon cancer	0.000702	0.00205	CcSEcCtD
Brimonidine—Nervous system disorder—Capecitabine—colon cancer	0.0007	0.00204	CcSEcCtD
Brimonidine—Eye disorder—Methotrexate—colon cancer	0.000699	0.00204	CcSEcCtD
Brimonidine—Tachycardia—Capecitabine—colon cancer	0.000697	0.00203	CcSEcCtD
Brimonidine—Cardiac disorder—Methotrexate—colon cancer	0.000694	0.00203	CcSEcCtD
Brimonidine—Skin disorder—Capecitabine—colon cancer	0.000693	0.00202	CcSEcCtD
Brimonidine—Rash—Vincristine—colon cancer	0.000691	0.00202	CcSEcCtD
Brimonidine—Dermatitis—Vincristine—colon cancer	0.00069	0.00201	CcSEcCtD
Brimonidine—Headache—Vincristine—colon cancer	0.000686	0.002	CcSEcCtD
Brimonidine—Angiopathy—Methotrexate—colon cancer	0.000679	0.00198	CcSEcCtD
Brimonidine—Immune system disorder—Methotrexate—colon cancer	0.000676	0.00197	CcSEcCtD
Brimonidine—Dizziness—Fluorouracil—colon cancer	0.000676	0.00197	CcSEcCtD
Brimonidine—Mediastinal disorder—Methotrexate—colon cancer	0.000674	0.00197	CcSEcCtD
Brimonidine—Rash—Irinotecan—colon cancer	0.000673	0.00196	CcSEcCtD
Brimonidine—Dermatitis—Irinotecan—colon cancer	0.000672	0.00196	CcSEcCtD
Brimonidine—Headache—Irinotecan—colon cancer	0.000668	0.00195	CcSEcCtD
Brimonidine—Hypotension—Capecitabine—colon cancer	0.000667	0.00195	CcSEcCtD
Brimonidine—Mental disorder—Methotrexate—colon cancer	0.000655	0.00191	CcSEcCtD
Brimonidine—Erythema—Methotrexate—colon cancer	0.000651	0.0019	CcSEcCtD
Brimonidine—Nausea—Vincristine—colon cancer	0.000651	0.0019	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00065	0.0019	CcSEcCtD
Brimonidine—Insomnia—Capecitabine—colon cancer	0.000646	0.00188	CcSEcCtD
Brimonidine—Rash—Fluorouracil—colon cancer	0.000644	0.00188	CcSEcCtD
Brimonidine—Dermatitis—Fluorouracil—colon cancer	0.000644	0.00188	CcSEcCtD
Brimonidine—Paraesthesia—Capecitabine—colon cancer	0.000641	0.00187	CcSEcCtD
Brimonidine—Headache—Fluorouracil—colon cancer	0.00064	0.00187	CcSEcCtD
Brimonidine—Dysgeusia—Methotrexate—colon cancer	0.000638	0.00186	CcSEcCtD
Brimonidine—Dyspnoea—Capecitabine—colon cancer	0.000637	0.00186	CcSEcCtD
Brimonidine—Nausea—Irinotecan—colon cancer	0.000634	0.00185	CcSEcCtD
Brimonidine—Dyspepsia—Capecitabine—colon cancer	0.000628	0.00183	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000616	0.0018	CcSEcCtD
Brimonidine—Fatigue—Capecitabine—colon cancer	0.000616	0.0018	CcSEcCtD
Brimonidine—Vision blurred—Methotrexate—colon cancer	0.000614	0.00179	CcSEcCtD
Brimonidine—Pain—Capecitabine—colon cancer	0.000611	0.00178	CcSEcCtD
Brimonidine—Nausea—Fluorouracil—colon cancer	0.000607	0.00177	CcSEcCtD
Brimonidine—Cough—Methotrexate—colon cancer	0.000568	0.00166	CcSEcCtD
Brimonidine—Chest pain—Methotrexate—colon cancer	0.000554	0.00162	CcSEcCtD
Brimonidine—Myalgia—Methotrexate—colon cancer	0.000554	0.00162	CcSEcCtD
Brimonidine—Arthralgia—Methotrexate—colon cancer	0.000554	0.00162	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000551	0.00161	CcSEcCtD
Brimonidine—Discomfort—Methotrexate—colon cancer	0.000548	0.0016	CcSEcCtD
Brimonidine—Infection—Methotrexate—colon cancer	0.000528	0.00154	CcSEcCtD
Brimonidine—Hypersensitivity—Capecitabine—colon cancer	0.000526	0.00153	CcSEcCtD
Brimonidine—Nervous system disorder—Methotrexate—colon cancer	0.000521	0.00152	CcSEcCtD
Brimonidine—Skin disorder—Methotrexate—colon cancer	0.000516	0.00151	CcSEcCtD
Brimonidine—Asthenia—Capecitabine—colon cancer	0.000512	0.00149	CcSEcCtD
Brimonidine—Pruritus—Capecitabine—colon cancer	0.000505	0.00147	CcSEcCtD
Brimonidine—Hypotension—Methotrexate—colon cancer	0.000497	0.00145	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000484	0.00141	CcSEcCtD
Brimonidine—Insomnia—Methotrexate—colon cancer	0.000481	0.0014	CcSEcCtD
Brimonidine—Paraesthesia—Methotrexate—colon cancer	0.000477	0.00139	CcSEcCtD
Brimonidine—Dyspnoea—Methotrexate—colon cancer	0.000474	0.00138	CcSEcCtD
Brimonidine—Somnolence—Methotrexate—colon cancer	0.000472	0.00138	CcSEcCtD
Brimonidine—Dizziness—Capecitabine—colon cancer	0.000472	0.00138	CcSEcCtD
Brimonidine—Dyspepsia—Methotrexate—colon cancer	0.000468	0.00137	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000459	0.00134	CcSEcCtD
Brimonidine—Fatigue—Methotrexate—colon cancer	0.000458	0.00134	CcSEcCtD
Brimonidine—Pain—Methotrexate—colon cancer	0.000454	0.00133	CcSEcCtD
Brimonidine—Rash—Capecitabine—colon cancer	0.00045	0.00131	CcSEcCtD
Brimonidine—Dermatitis—Capecitabine—colon cancer	0.00045	0.00131	CcSEcCtD
Brimonidine—Headache—Capecitabine—colon cancer	0.000447	0.00131	CcSEcCtD
Brimonidine—Nausea—Capecitabine—colon cancer	0.000424	0.00124	CcSEcCtD
Brimonidine—Hypersensitivity—Methotrexate—colon cancer	0.000392	0.00114	CcSEcCtD
Brimonidine—Asthenia—Methotrexate—colon cancer	0.000381	0.00111	CcSEcCtD
Brimonidine—Pruritus—Methotrexate—colon cancer	0.000376	0.0011	CcSEcCtD
Brimonidine—Dizziness—Methotrexate—colon cancer	0.000351	0.00103	CcSEcCtD
Brimonidine—Rash—Methotrexate—colon cancer	0.000335	0.000978	CcSEcCtD
Brimonidine—Dermatitis—Methotrexate—colon cancer	0.000335	0.000977	CcSEcCtD
Brimonidine—Headache—Methotrexate—colon cancer	0.000333	0.000972	CcSEcCtD
Brimonidine—Nausea—Methotrexate—colon cancer	0.000316	0.000921	CcSEcCtD
